Intracerebral Hemorrhage in Patients With COVID-19: An Analysis From the COVID-19 Cardiovascular Disease Registry

Stroke. 2021 Jul;52(7):e321-e323. doi: 10.1161/STROKEAHA.121.034215. Epub 2021 Jun 4.

Authors

Audrey C Leasure¹, Yosef M Khan², Raakhee Iyer², Mitchell S V Elkind³, Lauren H Sansing¹, Guido J Falcone¹, Kevin N Sheth¹

Affiliations

¹ Department of Neurology, Yale School of Medicine, New Haven, CT (A.C.L., L.H.S., G.J.F., K.N.S.).
² Health Informatics and Analytics, Centers for Health Metrics and Evaluation, American Heart Association, Dallas, TX (Y.M.K., R.I.).
³ Department of Neurology, Vagelos College of Physicians and Surgeons, and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY (M.S.V.E.).

Abstract

[Figure: see text].

Keywords: cardiovascular disease; cerebral hemorrhage; coronavirus; hospitals; prevalence.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Age Factors
Aged
Anticoagulants / therapeutic use
C-Reactive Protein / metabolism
COVID-19 / epidemiology*
COVID-19 / metabolism
COVID-19 / therapy
Cerebral Hemorrhage / epidemiology*
Cerebral Hemorrhage / metabolism
Extracorporeal Membrane Oxygenation / statistics & numerical data
Female
Heart Disease Risk Factors
Hospital Mortality
Hospitalization
Humans
Intensive Care Units / statistics & numerical data
Interleukin-6 / metabolism
Male
Middle Aged
Registries
Respiration, Artificial / statistics & numerical data
Risk Factors
SARS-CoV-2
Sex Factors
United States / epidemiology
Young Adult

Substances

Anticoagulants
Interleukin-6
C-Reactive Protein

Grants and funding